Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""Lymphocytes, Tumor-Infiltrating"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 1687 results
Title:
Prognostic Value of Immunoscore in Colorectal Carcinomas.
Authors:
Imen H; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Amira H; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Fatma K; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Raja J; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Mariem S; Department of Gastroenterology, Habib Thameur Hospital, Tunis, Tunisia.
Haithem Z; Department of Surgery, Habib Thameur Hospital, Tunis, Tunisia.
Ehsene BB; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Aschraf C; Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Show more
Source:
International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 58-65. Date of Electronic Publication: 2023 Apr 25.
Publication Type:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/pathology
Humans ; Middle Aged ; Prognosis ; Reproducibility of Results ; Retrospective Studies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study.
Authors:
Kim DH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lim Y; Lunit, Seoul, Republic of Korea.
Kim S; Lunit, Seoul, Republic of Korea.
Ock CY; Lunit, Seoul, Republic of Korea.
Youk J; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim HJ; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
Koh J; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
Jung KC; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
Na KJ; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Kang CH; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Show more
Source:
Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (30), pp. 3001-3011. Date of Electronic Publication: 2023 Sep 07.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Neoplasms, Glandular and Epithelial*/pathology
Humans ; Retrospective Studies ; Longitudinal Studies ; Artificial Intelligence ; Biomarkers ; Prognosis
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.
Authors:
Lu Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tong Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fei X; Department of Pathology, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Show more
Source:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16264-16278. Date of Electronic Publication: 2023 Jun 27.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Breast Neoplasms*/diagnosis
Biomarkers, Tumor ; Disease-Free Survival ; In Situ Hybridization, Fluorescence ; Prognosis ; Receptor, ErbB-2 ; Retrospective Studies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The expression profiles of signature genes from CD103 tumour-infiltrating lymphocyte subsets predict breast cancer survival.
Authors:
Xia ZA; Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China.
Lu C; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Pan C; School of Clinical Medicine, Hunan University of Traditional Chinese Medicine, Changsha, 410208, China.
Li J; Department of Emergency, Xiangya Hospital, Central South University, Changsha, 410008, China.
Li J; Department of Nuclear Medicine, Peking University Shenzhen Hospital, Guangdong, 518036, China.
Mao Y; Department of Radiology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Sun L; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China. .; Department of Oncology, Xiangya Cancer Center, XiangyaHospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China. .; Center for Molecular Imaging of Central, South University, Xiangya Hospital, Changsha, 410008, China. .
He J; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China. .; Department of Oncology, Xiangya Cancer Center, XiangyaHospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .
Show more
Source:
BMC medicine [BMC Med] 2023 Jul 24; Vol. 21 (1), pp. 268. Date of Electronic Publication: 2023 Jul 24.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/immunology
Breast Neoplasms*/drug therapy
Breast Neoplasms*/immunology
Humans ; Prognosis ; Antineoplastic Agents/therapeutic use
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Authors:
Pizarro D; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.
Romero I; Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.
Pérez-Mies B; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain.
Redondo A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital La Paz, IdiPAZ, 28046 Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital Universitario La Paz, 28029 Madrid, Spain.; Faculty of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.
Caniego-Casas T; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Carretero-Barrio I; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain.
Cristóbal E; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Gutiérrez-Pecharromán A; Pathology Department, University Hospital Getafe, 28905 Getafe, Spain.
Santaballa A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital La Fe, 46026 Valencia, Spain.
D'Angelo E; Department of Medical, Oral, and Biotechnological Sciences, University 'G.D'Annunzio' of Chieti-Pescara, 66013 Chieti, Italy.
Hardisson D; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital Universitario La Paz, 28029 Madrid, Spain.; Faculty of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.; Pathology Department, University Hospital La Paz, 28046 Madrid, Spain.
Vieites B; Pathology Department, University Hospital Virgen del Rocío, 41013 Sevilla, Spain.
Matías-Guiu X; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Pathology and Medical Oncology Departments, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, 25003 Lleida, Spain.; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, 08007 Barcelona, Spain.
Estévez P; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Seville Biomedical Research Institute (IBIS), 41013 Sevilla, Spain.
Guerra E; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.
Prat J; Pathology Department, Emeritus Faculty, Autonomous University of Barcelona, 08193 Barcelona, Spain.
Poveda A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Initia Oncología, Hospital Quironsalud Valencia, 46010 Valencia, Spain.
López-Guerrero JA; Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.
Palacios J; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 06; Vol. 24 (13). Date of Electronic Publication: 2023 Jul 06.
Publication Type:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Ovarian Neoplasms*/pathology
Humans ; Female ; Prognosis ; Retrospective Studies ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Mutation
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study.
Authors:
Tenggara JB; Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, RW.5, Kec. Senen, Central Jakarta, Jakarta, 10430, Indonesia. .; Division of Hematology and Medical Oncology, Department of Internal Medicine, MRCCC Siloam Hospital Jakarta, Jakarta, Indonesia. .
Rachman A; Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, RW.5, Kec. Senen, Central Jakarta, Jakarta, 10430, Indonesia.; Division of Hematology and Medical Oncology, Department of Internal Medicine, MRCCC Siloam Hospital Jakarta, Jakarta, Indonesia.
Prihartono J; Department of Community Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Rachmadi L; Department of Anatomical Pathology, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Panigoro SS; Department of Surgical Oncology, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Heriyanto DS; Department of Anatomical Pathology, Dr. Sardjito Hospital-Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Sutandyo N; Division of Hematology and Medical Oncology, Department of Internal Medicine, Dharmais National Cancer Hospital, Jakarta, Indonesia.
Nasution IR; Division of Hematology and Medical Oncology, Gatot Soebroto Army Hospital Jakarta, Jakarta, Indonesia.
Rahadiati FB; Department of Anatomical Pathology, Gatot Soebroto Army Hospital Jakarta, Jakarta, Indonesia.
Steven R; Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, RW.5, Kec. Senen, Central Jakarta, Jakarta, 10430, Indonesia.; Division of Hematology and Medical Oncology, Department of Internal Medicine, MRCCC Siloam Hospital Jakarta, Jakarta, Indonesia.
Betsy R; Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Juanputra S; Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Sudoyo AW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Jl. Pangeran Diponegoro No. 71, RW.5, Kec. Senen, Central Jakarta, Jakarta, 10430, Indonesia.; Division of Hematology and Medical Oncology, Department of Internal Medicine, MRCCC Siloam Hospital Jakarta, Jakarta, Indonesia.
Show more
Source:
BMC research notes [BMC Res Notes] 2024 Feb 02; Vol. 17 (1), pp. 44. Date of Electronic Publication: 2024 Feb 02.
Publication Type:
Multicenter Study; Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/pathology
Humans ; B7-H1 Antigen ; CD8-Positive T-Lymphocytes/metabolism ; Cohort Studies ; Forkhead Transcription Factors/genetics ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoadjuvant Therapy ; CD4 Antigens ; CD8 Antigens
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Exploration of the relationship between tumor-infiltrating lymphocyte score and histological grade in breast cancer.
Authors:
Kang D; Department of Pathology, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Wang C; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Han Z; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Zheng L; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China.
Guo W; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Fu F; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Qiu L; College of Physics and Electronic Information Engineering, Minjiang University, 350108, Fuzhou, P. R. China.
Han X; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China.
He J; School of Science, Jimei University, 361021, Xiamen, P. R. China. .
Li L; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China. .
Chen J; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China. .
Show more
Source:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 318. Date of Electronic Publication: 2024 Mar 07.
Publication Type:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating/pathology ; Prognosis
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Authors:
Dai X; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.; Jiangxi Key Laboratory for Individual Cancer Therapy, 17 Yongwai Street, Nanchang, Jiangxi Province, 330006, China.
Wu Z; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.; Jiangxi Key Laboratory for Individual Cancer Therapy, 17 Yongwai Street, Nanchang, Jiangxi Province, 330006, China.
Ruan R; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.; Jiangxi Key Laboratory for Individual Cancer Therapy, 17 Yongwai Street, Nanchang, Jiangxi Province, 330006, China.
Chen J; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.; Jiangxi Key Laboratory for Individual Cancer Therapy, 17 Yongwai Street, Nanchang, Jiangxi Province, 330006, China.
Huang C; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.; Jiangxi Key Laboratory for Individual Cancer Therapy, 17 Yongwai Street, Nanchang, Jiangxi Province, 330006, China.
Lei W; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.
Yao Y; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.
Li L; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China.
Tang X; Department of Oncology, Jiangxi Provincial Chest Hospital, Nanchang, Jiangxi Province, 330006, China. .
Xiong J; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China. .
Feng M; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China. .
Deng J; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, China. .; Postdoctoral Innovation Practice Base, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China. .
Show more
Source:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 07; Vol. 22 (1), pp. 168. Date of Electronic Publication: 2024 Mar 07.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/pathology
Animals ; Humans ; Mice ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes ; Lymphocytes, Tumor-Infiltrating ; Nuclear Proteins ; Repressor Proteins ; Tumor Escape
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Authors:
Arqueros C; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Gallardo A; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Vidal S; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Osuna-Gómez R; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Tibau A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lidia Bell O; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Ramón Y Cajal T; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lerma E; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Lobato-Delgado B; Unitat de Genòmica de Malalties Complexes, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Salazar J; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Barnadas A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Publication Type:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Neoadjuvant Therapy/adverse effects ; Clinical Relevance ; Retrospective Studies ; Biomarkers, Tumor/analysis ; Lymphocytes, Tumor-Infiltrating ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Diffuse large B-cell lymphoma: the significance of CD8 tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway.
Authors:
Zhu Q; Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, 637000, China.; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China.
Yang Y; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China.
Chen K; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China.
Zhang Q; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China.
Huang Y; Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, 637000, China.; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China.
Jian S; Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, 637000, China. .; Department of Pathology, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan Nan Road, Nanchong, 637000, Sichuan, China. .
Show more
Source:
Journal of translational medicine [J Transl Med] 2024 Feb 18; Vol. 22 (1), pp. 174. Date of Electronic Publication: 2024 Feb 18.
Publication Type:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
Hepatitis A Virus Cellular Receptor 2*/metabolism
Lymphoma, Large B-Cell, Diffuse*/pathology
Galectins*/metabolism
Humans ; Ligands ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration.
Authors:
Ying F; Department of Gastroenterology, Xianju People's Hospital, NO.53 North East Road, Xianju County, Taizhou, Zhejiang Province, China.
Chen X; Department of Gastroenterology, Xianju People's Hospital, NO.53 North East Road, Xianju County, Taizhou, Zhejiang Province, China.
Lv L; Department of Gastroenterology, Xianju People's Hospital, NO.53 North East Road, Xianju County, Taizhou, Zhejiang Province, China. .
Show more
Source:
Scientific reports [Sci Rep] 2024 Feb 16; Vol. 14 (1), pp. 3922. Date of Electronic Publication: 2024 Feb 16.
Publication Type:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/genetics
Glycerol Kinase*/chemistry
Humans ; B-Lymphocytes ; Carcinoma ; Prognosis ; Lymphocytes, Tumor-Infiltrating/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
Authors:
Tushoski-Alemán GW; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Herremans KM; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Underwood PW; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Akki A; Department of Pathology, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Riner AN; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Trevino JG; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Han S; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Hughes SJ; Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Show more
Source:
PloS one [PLoS One] 2024 Feb 12; Vol. 19 (2), pp. e0297325. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Publication Type:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Lymphocytes, Tumor-Infiltrating ; CD8-Positive T-Lymphocytes ; Inflammation/pathology ; Prognosis ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer.
Authors:
Shiomi K; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Ichinoe M; Department of Pathology, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Ushiwata A; Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
Eshima K; Department of Biosciences, Kitasato University School of Sciences, Sagamihara-shi, Japan.
Nagashio R; Department of Applied Tumor Pathology, Graduate School of Medical Sciences, Kitasato University, Sagamihara-shi, Japan.
Hayashi S; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Sonoda D; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Kondo Y; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Maruyama R; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Mikubo M; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Murakumo Y; Department of Pathology, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Satoh Y; Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara-shi, Japan.
Show more
Source:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (4), pp. 299-306. Date of Electronic Publication: 2023 Dec 20.
Publication Type:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Squamous Cell*/pathology
Humans ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoplasm Recurrence, Local/pathology ; Prognosis ; CD8-Positive T-Lymphocytes/pathology ; Epithelial Cells/pathology ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Tumor-infiltrating CD36 T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer.
Authors:
Ao YQ; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Gao J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang LX; Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330000, P.R. China.
Deng J; Institute of Vascular Disease, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang S; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Lin M; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang HK; CAS Key Laboratory of Molecular Virology and Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Ding JY; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China. .; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. .
Jiang JH; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, P. R. China. .; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. .
Show more
Source:
BMC cancer [BMC Cancer] 2023 Apr 21; Vol. 23 (1), pp. 367. Date of Electronic Publication: 2023 Apr 21.
Publication Type:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/immunology
CD8-Positive T-Lymphocytes*
Lymphocytes, Tumor-Infiltrating*
Tumor Microenvironment*/immunology
Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/immunology ; Prognosis ; CD36 Antigens/immunology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer.
Authors:
Li C; Department of Urology, Shenshan Medical Center, Memorial Hospital of Sun Yat-Sen University, Shanwei, Guangdong, People's Republic of China.
Xie W; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China. .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China. .; Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, Guangdong, People's Republic of China. .
Show more
Source:
BMC bioinformatics [BMC Bioinformatics] 2023 Mar 27; Vol. 24 (1), pp. 118. Date of Electronic Publication: 2023 Mar 27.
Publication Type:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Humans ; Cluster Analysis ; Databases, Factual ; Immunotherapy ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating Lymphocytes.
Authors:
Dawidowicz M; Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Ksatowice, Poland.
Kula A; Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Ksatowice, Poland.
Mielcarska S; Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.
Kiczmer P; Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 13-15 3 Maja, 41-800 Zabrze, Poland.
Skiba H; Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 13-15 3 Maja, 41-800 Zabrze, Poland.
Krygier M; Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 13-15 3 Maja, 41-800 Zabrze, Poland.
Chrabańska M; Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 13-15 3 Maja, 41-800 Zabrze, Poland.
Piecuch J; Department of General and Bariatric Surgery and Emergency Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
Szrot M; Department of General and Bariatric Surgery and Emergency Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
Robotycka J; Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.
Ochman B; Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.
Strzałkowska B; Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.
Czuba Z; Department of Microbiology and Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Świętochowska E; Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.
Waniczek D; Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Ksatowice, Poland.
Show more
Source:
Cells [Cells] 2023 Mar 10; Vol. 12 (6). Date of Electronic Publication: 2023 Mar 10.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Colorectal Neoplasms*/pathology
Humans ; Immunohistochemistry ; Microsatellite Repeats/genetics ; CD8-Positive T-Lymphocytes/pathology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin.
Authors:
De Leon-Rodríguez SG; UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Inmunoquímica, Mexico City 06720, Mexico.; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Aguilar-Flores C; UMAE Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Gajón JA; UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Inmunoquímica, Mexico City 06720, Mexico.; Posgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Mantilla A; Servicio de Patología, Hospital de Oncología Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Gerson-Cwilich R; Cancer Center, Medical Center American British Cowdray, Mexico City 01120, Mexico.
Martínez-Herrera JF; Cancer Center, Medical Center American British Cowdray, Mexico City 01120, Mexico.; Latin American Network for Cancer Research (LAN-CANCER), Lima 11702, Peru.
Rodríguez-Soto BE; International Cancer Center, Campus Santa Fe, Mexico City 05348, Mexico.
Gutiérrez-Quiroz CT; UMAE Hospital de Especialidades, Centro Médico Nacional General Manuel Avila Camacho, Puebla 72000, Mexico.
Pérez-Koldenkova V; Laboratorio Nacional de Microscopía Avanzada-IMSS, División de Desarrollo de la Investigación, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Muñoz-Cruz S; UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Inmunoquímica, Mexico City 06720, Mexico.
Bonifaz LC; UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Inmunoquímica, Mexico City 06720, Mexico.; Coordinación de Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Fuentes-Pananá EM; Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 01; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 01.
Publication Type:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*/immunology
Melanoma*/immunology
Melanoma*/pathology
Skin Neoplasms*/immunology
Skin Neoplasms*/pathology
Dendritic Cells*/immunology
Lymphocytes, Tumor-Infiltrating*/immunology
Skin*/radiation effects
Humans ; B7-H1 Antigen/metabolism ; Ultraviolet Rays ; Radiation Exposure ; Melanoma, Cutaneous Malignant
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy.
Authors:
Feng H; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Qiu L; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Shi Z; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Sheng Y; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Zhao P; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Zhou D; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Li F; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Yu H; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
You Y; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Wang H; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Li M; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Zhu S; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Du Y; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Cui J; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Sun J; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Liu Y; Grit Biotechnology Co., Ltd. Shanghai, Shanghai, People's Republic of China.
Jiang H; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Wu X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, People's Republic of China.
Show more
Source:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3313-3327. Date of Electronic Publication: 2022 Aug 26.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/metabolism
Ovarian Neoplasms*/pathology
Humans ; Female ; Immunotherapy, Adoptive ; CD8-Positive T-Lymphocytes/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.
Authors:
Mlynska A; National Cancer Institute, LT-08406 Vilnius, Lithuania.; Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.
Gibavičienė J; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Kutanovaitė O; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Senkus L; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Mažeikaitė J; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Kerševičiūtė I; Life Sciences Center, Vilnius University, LT-01513 Vilnius, Lithuania.
Maskoliūnaitė V; Life Sciences Center, Vilnius University, LT-01513 Vilnius, Lithuania.; National Center of Pathology, LT-08406 Vilnius, Lithuania.
Rupeikaitė N; Life Sciences Center, Vilnius University, LT-01513 Vilnius, Lithuania.
Sabaliauskaitė R; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Gaiževska J; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Suveizdė K; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Kraśko JA; National Cancer Institute, LT-08406 Vilnius, Lithuania.; Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.
Dobrovolskienė N; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Paberalė E; National Cancer Institute, LT-08406 Vilnius, Lithuania.; Life Sciences Center, Vilnius University, LT-01513 Vilnius, Lithuania.
Žymantaitė E; National Cancer Institute, LT-08406 Vilnius, Lithuania.
Pašukonienė V; National Cancer Institute, LT-08406 Vilnius, Lithuania.; Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.
Show more
Source:
Biomolecules [Biomolecules] 2024 Jan 31; Vol. 14 (2). Date of Electronic Publication: 2024 Jan 31.
Publication Type:
Journal Article
MeSH Terms:
Melanoma*/pathology
Humans ; Biomarkers/metabolism ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Immunity ; Transcriptome ; Tumor Microenvironment/genetics ; Biomarkers, Tumor/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.
Authors:
Tanaka R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States of America.
Eguchi S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ohira G; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tanaka S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Amano R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tanaka H; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yashiro M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Show more
Source:
PloS one [PLoS One] 2023 Jan 24; Vol. 18 (1), pp. e0280348. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023).
Publication Type:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Biliary Tract Neoplasms*/surgery
Biliary Tract Neoplasms*/pathology
Humans ; Prognosis ; Retrospective Studies ; CD8-Positive T-Lymphocytes ; Macrophages ; Tumor Microenvironment
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 1687 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.